lease liabilities                     12,310        11,047        1,520 
Current portion of finance 
 lease liabilities                     51,160        51,984        7,153 
Short-term borrowing from 
 third parties                         71,181       105,584       14,529 
Short-term borrowing from 
 related party                          7,000         9,500        1,307 
Current portion of long-term 
 debt (i)                             291,950             -            - 
Total current liabilities             885,148       577,620       79,482 
                              ---------------  ------------  ----------- 
 
Non-current liabilities 
Consideration payable to 
 WeBank (ii)                                -        41,947        5,772 
Finance lease liabilities           1,191,246     1,210,420      166,559 
Operating lease liabilities           154,846       153,171       21,077 
Total non-current 
 liabilities                        1,346,092     1,405,538      193,408 
                              ---------------  ------------  ----------- 
 
Total liabilities                   2,231,240     1,983,158      272,890 
                              ===============  ============  =========== 
 
Mezzanine equity 
Redeemable non-controlling 
 interests                            149,991       151,641       20,866 
Total Mezzanine equity                149,991       151,641       20,866 
                              ---------------  ------------  ----------- 
 
Shareholders' deficit 
Ordinary shares                        39,806        39,807        5,478 
Additional paid-in capital         18,928,837    18,942,103    2,606,521 
Subscription receivable from 
 shareholders                       (107,879)      (80,786)     (11,117) 
Accumulated other 
 comprehensive income                 225,090       223,874       30,806 
Accumulated deficit              (19,378,705)  (19,430,176)  (2,673,681) 
Total Uxin's shareholders' 
 deficit                            (292,851)     (305,178)     (41,993) 
                              ---------------  ------------  ----------- 
Non-controlling interests               (231)         (240)         (33) 
                              ---------------  ------------  ----------- 
Total shareholders' deficit         (293,082)     (305,418)     (42,026) 
                              ===============  ============  =========== 
 
Total liabilities, mezzanine 
 equity and shareholders' 
 deficit                            2,088,149     1,829,381      251,730 
                              ===============  ============  =========== 
 
 
 
 
* Share-based compensation charges included are as follows: 
 
                                   For the three months ended June 30, 
                                 --------------------------------------- 
                                     2023                 2024 
                                 -------------  ------------------------ 
                                      RMB             RMB          US$ 
Sales and marketing                        332              136       19 
General and administrative               9,425           11,784    1,622 
Research and development                   394              128       18 
 
 
                              Uxin Limited 
         Unaudited Reconciliations of GAAP And Non-GAAP Results 
     (In thousands except for number of shares and per share data) 
 
 
                                For the three months ended June 30, 
                           --------------------------------------------- 
                               2023                    2024 
                           -------------  ------------------------------ 
                                RMB            RMB             US$ 
Net loss, net of tax            (91,602)        (49,830)         (6,855) 
 
Add: Income tax expense              165              38               5 
Interest income                    (102)            (16)             (2) 
Interest expenses                  5,120          22,858           3,145 
Depreciation                       6,413          16,577           2,281 
EBITDA                          (80,006)        (10,373)         (1,426) 
                           -------------  --------------  -------------- 
 
Add: Share-based 
 compensation expenses            10,151          12,048           1,659 
- Sales and marketing                332             136              19 
- General and 
 administrative                    9,425          11,784           1,622 
- Research and 
 development                         394             128              18 
Other income                     (2,367)           (633)            (87) 
Other expenses                       272             800             110 
Foreign exchange 
 (losses)/gains                      425           (479)            (66) 
Dividend from long-term 
 investment                     (11,970)               -               - 
Net gain from 
 extinguishment of debt                -        (35,222)         (4,847) 
Fair value impact of the 
 issuance of senior 
 convertible preferred 
 shares                           36,869               -               - 
                           -------------  --------------  -------------- 
 
Non-GAAP adjusted EBITDA        (46,626)        (33,859)         (4,657) 
                           =============  ==============  ============== 
 
                                For the three months ended June 30, 
                           --------------------------------------------- 
                                    2023               2024 
                           -------------  ------------------------------ 
                                RMB            RMB             US$ 
Net loss attributable to 
 ordinary shareholders          (91,600)        (51,471)         (7,081) 
Add: Share-based 
 compensation expenses            10,151          12,048           1,659 
- Sales and marketing                332             136              19 
- General and 
 administrative                    9,425          11,784           1,622 
- Research and 
 development                         394             128              18 
Fair value impact of the 
 issuance of senior 
 convertible preferred 
 shares                           36,869               -               - 
Add: accretion on 
 redeemable non- 
 controlling interests                 -           1,650             227 
 
Non-GAAP adjusted net 
 loss attributable to 
 ordinary shareholders          (44,580)        (37,773)         (5,195) 
                           =============  ==============  ============== 
 
Net loss per share for 
 ordinary shareholders - 
 basic                            (0.06)               -               - 
Net loss per share for 
 ordinary shareholders - 
 diluted                          (0.06)               -               - 
Non-GAAP adjusted net 
 loss to ordinary 
 shareholders per share - 
 basic and diluted                (0.03)               -               - 
Weighted average shares 
 outstanding - basic       1,423,659,403  56,412,679,304  56,412,679,304 
Weighted average shares 
 outstanding - diluted     1,423,659,403  56,412,679,304  56,412,679,304 
 
Note: The conversion of Renminbi (RMB) into U.S. dollars $(USD)$ is based 
on the certified exchange rate of USD1.00 = RMB7.2672 as of June 28, 
2024 set forth in the H.10 statistical release of the Board of Governors 
of the Federal Reserve System. 
 

View original content:https://www.prnewswire.com/news-releases/uxin-reports-unaudited-first-quarter-of-fiscal-year-2025-financial-results-302255388.html

SOURCE Uxin Limited

(END) Dow Jones Newswires

September 23, 2024 04:34 ET (08:34 GMT)